— Know what they know.
Not Investment Advice
Also trades as: 0J9P.L (LSE) · $vol 0M

INCY NASDAQ

Incyte Corporation
1W: -0.2% 1M: +0.7% 3M: -3.9% YTD: -4.0% 1Y: +49.2% 3Y: +50.6% 5Y: +17.9%
$97.16
-0.25 (-0.26%)
 
Weekly Expected Move ±3.7%
$88 $92 $95 $99 $102
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 55 · $19.4B mcap · 198M float · 0.766% daily turnover · Short 64% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$5.1B +21.2% ▲
5Y CAGR: +14.0%
Gross Profit
$4.7B +21.7% ▲
5Y CAGR: +13.4%
Operating Income
$1.3B +1575.4% ▲
Net Income
$1.3B +3845.0% ▲
EPS (Diluted)
$6.41 +4173.3% ▲
EBITDA
$1.8B +331.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$3.0B$3.4B$3.7B$4.2B$5.1B
YoY Growth+12.0%+13.7%+8.9%+14.8%+21.2%
Cost of Revenue$187M$253M$315M$378M$439M
Gross Profit$2.8B$3.1B$3.4B$3.9B$4.7B
Gross Margin93.7%92.5%91.5%91.1%91.5%
R&D Expenses$1.5B$1.6B$1.6B$2.6B$2.0B
SG&A Expenses$703M$956M$1.1B$1.2B$1.4B
Operating Expenses$2.2B$2.5B$2.7B$3.8B$3.4B
Operating Income$638M$600M$652M$80M$1.3B
Operating Margin21.3%17.7%17.6%1.9%26.1%
Interest Expense$2M$3M$3M$2M$2M
Income Before Tax$570M$529M$834M$317M$1.7B
Tax Expense-$378M$188M$237M$284M$378M
Net Income$949M$341M$598M$33M$1.3B
Net Margin31.8%10.0%16.2%0.8%25.0%
EPS (Diluted)$4.27$1.52$2.65$0.15$6.41
EBITDA$630M$600M$919M$408M$1.8B
Shares Outstanding222M224M226M211M201M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms